Protection from AMP 579 can be added to that from either cariporide or ischemic preconditioning in ischemic rabbit heart

Journal of Cardiovascular Pharmacology

Volumn 40, Issue 4, 2002, Pages 510-518

  Xu, Zhelong ^a   Jiao, Zhe ^a   Cohen, Michael V ^a   Downey, James M ^a  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

AMP 579; Cariporide; Ischemic preconditioning; Myocardial infarction

Indexed keywords

4 [7 [[1 [(3 CHLORO 2 THIENYL)METHYL]PROPYL]AMINO] 3H IMIDAZO[4,5 B]PYRIDIN 3 YL] N ETHYL 2,3 DIHYDROXYCYCLOPENTANECARBOXAMIDE; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A2 RECEPTOR AGONIST; CARIPORIDE; SODIUM PROTON EXCHANGE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG INFUSION; DRUG MECHANISM; DRUG POTENTIATION; FEMALE; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART SURGERY; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALS; CARDIOTONIC AGENTS; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; GUANIDINES; HEART; IMIDAZOLES; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MYOCARDIAL ISCHEMIA; PYRIDINES; RABBITS; SULFONES;

EID: 0036784838     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200210000-00003     Document Type: Article

References (29)

1. 2 receptor agonist AMP 579 in a porcine model of myocardial infarction. J Pharmacol Exp Ther 1998;286:611-618.
2. 2-receptor agonist AMP 579: coronary hemodynamic and cardioprotective effects in the canine myocardium. J Cardiovasc Pharmacol 1999;33:703-710.
3. Budde JM, Velez DA, Zhao Z-Q, et al. Comparative study of AMP579 and adenosine in inhibition of neutrophil-mediated vascular and myocardial injury during 24 h of reperfusion. Cardiovasc Res 2000;47:294-305.
4. Xu Z, Yang X-M, Cohen MV, Neumann T, Heusch G, Downey JM. Limitation of infarct size in rabbit hearts by the novel adenosine receptor agonist AMP 579 administered at reperfusion. J Mol Cell Cardiol 2000;32:2339-2347.
5. 2 receptors. J Cardiovasc Pharmacol 2001;38:474-481.
6. Xu Z, Cohen MV, Downey JM, Vanden Hoek TL, Yao Z. Attenuation of oxidant stress during reoxygenation by AMP 579 in cardiomyocytes. Am J Physiol 2001;281: H2585-H2589.
7. + exchange inhibitor, Hoe 642: difference from preconditioning in the role of protein kinase C. J Am Coll Cardiol 1997;29:693-701.
8. Scholz W, Albus U, Counillon L, et al. Protective effects of HOE642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischemia and reperfusion. Cardiovasc Res 1995;29:260-268.
9. + exchange inhibition in a regionally ischemic, reperfused porcine heart preparation with low residual blood flow. J Mol Cell Cardiol 1998;30:795-801.
10. + exchange inhibitor (SM-20550) protects from microvascular deterioration and myocardial injury after reperfusion. Eur J Pharmacol 1999;374:355-366.
11. + exchanger confers greater cardioprotection against 90 min of myocardial ischemia than ischemic preconditioning in dogs. Circulation 1999;100:2519-2526.
12. + exchange inhibition in ischemic, reperfused porcine hearts. Circulation 1995;92:912-917.
13. + exchange inhibitor reduces infarct size in pigs. Cardiovasc Res 1995;30:945-951.
14. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-1136.
15. 1 adenosine receptors in rabbit heart. Circulation 1991;84:350-356.
16. Goto M, Liu Y, Yang X-M, Ardell JL, Cohen MV, Downey JM. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res 1995;77:611-621.
17. Schultz JEJ, Rose E, Yao Z, Gross GJ. Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol 1995;268:H2157-H2161.
18. Ytrehus K, Liu Y, Downey JM. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol 1994;266:H1145-H1152.
19. National Research Council. Guide for the care and use of laboratory animals. 7th ed. Washington, D.C.: National Academy Press, 1996.
20. Van Winkle DM, Thornton JD, Downey DM, Downey JM. The natural history of preconditioning: cardioprotection depends on duration of transient ischemia and time to subsequent ischemia. Coron Artery Dis 1991;2:613-619.
21. Nakamura M, Zhao Z-Q, Clark KL, Velez DV, Guyton RA, Vinten-Johansen J. A novel adenosine analog, AMP579, inhibits neutrophil activation, adherence and neutrophil-mediated injury to coronary vascular endothelium. Eur J Pharmacol 2000;397:197-205.
22. Baxter GF, Ebrahim Z, Yellon DM. Amp579, an A1/A2a agonist, limits infarct size at reperfusion via a p42/p44 MAPK-dependent pathway. Circulation (Suppl II) 2000;102:II-212.
23. + exchange inhibitor cariporide in patients with acute anterior myocardial infarction undergoing direct PTCA. Circulation 2000;101:2902-2908.
24. + exchange inhibitor cariporide attenuates cell injury predominantly during ischemia and not at onset of reperfusion in porcine hearts with low residual blood flow. Circulation 2000;102:1977-1982.
25. 2+ overload and prolonged acidosis on reperfusion. Circulation 2000;101:2749-2755.
26. Linz W, Albus U, Crause P, et al. Dose-dependent reduction of myocardial infarct mass in rabbits by the NHE-1 inhibitor cariporide (HOE 642). Clin Exp Hypertens 1998;20:733-749.
27. + exchanger is critical to reperfusion damage and preconditioning in the isolated rat heart. Cardiovasc Res 2000;48:244-253.
28. 1-selective adenosine analogues protects the heart against infarction. Circulation 1992;85:659-665.
29. 3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart. Cardiovasc Res 1994;28:1057-1061.